RYR2, PTDSS1 and AREG genes are implicated in a Lebanese population-based study of copy number variation in autism

Jihane Soueid, Silva Kourtian, Nadine J. Makhoul, Joelle Makoukji, Sariah Haddad, Simona Ghanem, Firas Kobeissy, Rose Mary Boustany

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Autism Spectrum Disorders (ASDs) are a group of neurodevelopmental disorders characterized by ritualistic-repetitive behaviors and impaired verbal and non-verbal communication. Objectives were to determine the contribution of genetic variation to ASDs in the Lebanese. Affymetrix Cytogenetics Whole-Genome 2.7 M and CytoScan ™ HD Arrays were used to detect CNVs in 41 Lebanese autistic children and 35 non-autistic, developmentally delayed and intellectually disabled patients. 33 normal participants were used as controls. 16 de novo CNVs and 57 inherited CNVs, including recognized pathogenic 16p11.2 duplications and 2p16.3 deletions were identified. A duplication at 1q43 classified as likely pathogenic encompasses RYR2 as a potential ASD candidate gene. This previously identified CNV has been classified as both pathogenic, and, of uncertain significance. A duplication of unknown significance at 10q11.22, proposed as a modulator for phenotypic disease expression in Rett syndrome, was also identified. The novel potential autism susceptibility genes PTDSS1 and AREG were uncovered and warrant further genetic and functional analyses. Previously described and novel genetic targets in ASD were identified in Lebanese families with autism. These findings may lead to improved diagnosis of ASDs and informed genetic counseling, and may also lead to untapped therapeutic targets applicable to Lebanese and non-Lebanese patients.

Original languageEnglish
Article number19088
JournalScientific Reports
Volume6
DOIs
Publication statusPublished - 8 Jan 2016
Externally publishedYes

Fingerprint

Autistic Disorder
Population
Genes
Verbal Behavior
Rett Syndrome
Genetic Counseling
Cytogenetics
Communication
Autism Spectrum Disorder
Genome
Therapeutics

ASJC Scopus subject areas

  • General

Cite this

RYR2, PTDSS1 and AREG genes are implicated in a Lebanese population-based study of copy number variation in autism. / Soueid, Jihane; Kourtian, Silva; Makhoul, Nadine J.; Makoukji, Joelle; Haddad, Sariah; Ghanem, Simona; Kobeissy, Firas; Boustany, Rose Mary.

In: Scientific Reports, Vol. 6, 19088, 08.01.2016.

Research output: Contribution to journalArticle

Soueid, Jihane ; Kourtian, Silva ; Makhoul, Nadine J. ; Makoukji, Joelle ; Haddad, Sariah ; Ghanem, Simona ; Kobeissy, Firas ; Boustany, Rose Mary. / RYR2, PTDSS1 and AREG genes are implicated in a Lebanese population-based study of copy number variation in autism. In: Scientific Reports. 2016 ; Vol. 6.
@article{b48a884251e64b6fb2d2ab97f08a271e,
title = "RYR2, PTDSS1 and AREG genes are implicated in a Lebanese population-based study of copy number variation in autism",
abstract = "Autism Spectrum Disorders (ASDs) are a group of neurodevelopmental disorders characterized by ritualistic-repetitive behaviors and impaired verbal and non-verbal communication. Objectives were to determine the contribution of genetic variation to ASDs in the Lebanese. Affymetrix Cytogenetics Whole-Genome 2.7 M and CytoScan ™ HD Arrays were used to detect CNVs in 41 Lebanese autistic children and 35 non-autistic, developmentally delayed and intellectually disabled patients. 33 normal participants were used as controls. 16 de novo CNVs and 57 inherited CNVs, including recognized pathogenic 16p11.2 duplications and 2p16.3 deletions were identified. A duplication at 1q43 classified as likely pathogenic encompasses RYR2 as a potential ASD candidate gene. This previously identified CNV has been classified as both pathogenic, and, of uncertain significance. A duplication of unknown significance at 10q11.22, proposed as a modulator for phenotypic disease expression in Rett syndrome, was also identified. The novel potential autism susceptibility genes PTDSS1 and AREG were uncovered and warrant further genetic and functional analyses. Previously described and novel genetic targets in ASD were identified in Lebanese families with autism. These findings may lead to improved diagnosis of ASDs and informed genetic counseling, and may also lead to untapped therapeutic targets applicable to Lebanese and non-Lebanese patients.",
author = "Jihane Soueid and Silva Kourtian and Makhoul, {Nadine J.} and Joelle Makoukji and Sariah Haddad and Simona Ghanem and Firas Kobeissy and Boustany, {Rose Mary}",
year = "2016",
month = "1",
day = "8",
doi = "10.1038/srep19088",
language = "English",
volume = "6",
journal = "Scientific Reports",
issn = "2045-2322",
publisher = "Nature Publishing Group",

}

TY - JOUR

T1 - RYR2, PTDSS1 and AREG genes are implicated in a Lebanese population-based study of copy number variation in autism

AU - Soueid, Jihane

AU - Kourtian, Silva

AU - Makhoul, Nadine J.

AU - Makoukji, Joelle

AU - Haddad, Sariah

AU - Ghanem, Simona

AU - Kobeissy, Firas

AU - Boustany, Rose Mary

PY - 2016/1/8

Y1 - 2016/1/8

N2 - Autism Spectrum Disorders (ASDs) are a group of neurodevelopmental disorders characterized by ritualistic-repetitive behaviors and impaired verbal and non-verbal communication. Objectives were to determine the contribution of genetic variation to ASDs in the Lebanese. Affymetrix Cytogenetics Whole-Genome 2.7 M and CytoScan ™ HD Arrays were used to detect CNVs in 41 Lebanese autistic children and 35 non-autistic, developmentally delayed and intellectually disabled patients. 33 normal participants were used as controls. 16 de novo CNVs and 57 inherited CNVs, including recognized pathogenic 16p11.2 duplications and 2p16.3 deletions were identified. A duplication at 1q43 classified as likely pathogenic encompasses RYR2 as a potential ASD candidate gene. This previously identified CNV has been classified as both pathogenic, and, of uncertain significance. A duplication of unknown significance at 10q11.22, proposed as a modulator for phenotypic disease expression in Rett syndrome, was also identified. The novel potential autism susceptibility genes PTDSS1 and AREG were uncovered and warrant further genetic and functional analyses. Previously described and novel genetic targets in ASD were identified in Lebanese families with autism. These findings may lead to improved diagnosis of ASDs and informed genetic counseling, and may also lead to untapped therapeutic targets applicable to Lebanese and non-Lebanese patients.

AB - Autism Spectrum Disorders (ASDs) are a group of neurodevelopmental disorders characterized by ritualistic-repetitive behaviors and impaired verbal and non-verbal communication. Objectives were to determine the contribution of genetic variation to ASDs in the Lebanese. Affymetrix Cytogenetics Whole-Genome 2.7 M and CytoScan ™ HD Arrays were used to detect CNVs in 41 Lebanese autistic children and 35 non-autistic, developmentally delayed and intellectually disabled patients. 33 normal participants were used as controls. 16 de novo CNVs and 57 inherited CNVs, including recognized pathogenic 16p11.2 duplications and 2p16.3 deletions were identified. A duplication at 1q43 classified as likely pathogenic encompasses RYR2 as a potential ASD candidate gene. This previously identified CNV has been classified as both pathogenic, and, of uncertain significance. A duplication of unknown significance at 10q11.22, proposed as a modulator for phenotypic disease expression in Rett syndrome, was also identified. The novel potential autism susceptibility genes PTDSS1 and AREG were uncovered and warrant further genetic and functional analyses. Previously described and novel genetic targets in ASD were identified in Lebanese families with autism. These findings may lead to improved diagnosis of ASDs and informed genetic counseling, and may also lead to untapped therapeutic targets applicable to Lebanese and non-Lebanese patients.

UR - http://www.scopus.com/inward/record.url?scp=84953924619&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84953924619&partnerID=8YFLogxK

U2 - 10.1038/srep19088

DO - 10.1038/srep19088

M3 - Article

VL - 6

JO - Scientific Reports

JF - Scientific Reports

SN - 2045-2322

M1 - 19088

ER -